Literature DB >> 21170722

Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study.

Timothy L Lash1, Martin B Johansen, Steffen Christensen, John A Baron, Kenneth J Rothman, Jens G Hansen, Henrik Toft Sørensen.   

Abstract

We examined rates of first hospitalization for COPD, rates of 5-year mortality among patients hospitalized for COPD, and comparisons of mortality between COPD patients and a matched cohort free of COPD. We computed standardized rates of first COPD hospitalization. Using Cox regression, we compared 180- and 181-day to 5-year mortality among COPD patients with the comparison cohort. We used medical databases in Denmark (population 5.4 million) from 1997 to 2006. We included patients 40 years or older with first hospitalization for COPD (64,499) and an age- and gender-matched comparison cohort of persons without COPD hospitalization (322,495). We examined the incidence of COPD hospitalization and risks and rates of mortality in the 5 years after hospitalization. Standardized rates of first hospitalization for COPD declined from 276 per 100,000 person-years in 1999 to 231 per 100,000 person-years in 2006. Within 180 days of hospitalization, 16% of COPD patients and 2.4% of persons in the matched cohort died (adjusted hazard ratio = 7.00, 95% CI = 6.79-7.22). Between 181 days and 5 years, 46% of COPD patients who survived the first 180 days and 19% of persons in the comparison cohort died (adjusted hazard ratio = 2.91, 95% CI = 2.86-2.95). COPD and comorbid diseases interacted to increase mortality in the first 180 days, but not thereafter. COPD continues to be a major public health problem causing substantial mortality in the 5 years after hospitalization, particularly in the first 180 days and in patients with comorbid diseases.

Entities:  

Mesh:

Year:  2010        PMID: 21170722     DOI: 10.1007/s00408-010-9274-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  39 in total

1.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

2.  Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm.

Authors:  Roberto de Marco; Simone Accordini; Isa Cerveri; Angelo Corsico; Josep M Antó; Nino Künzli; Christer Janson; Jordi Sunyer; Deborah Jarvis; Susan Chinn; Paul Vermeire; Cecilie Svanes; Ursula Ackermann-Liebrich; Thorarinn Gislason; Joachim Heinrich; Bénédicte Leynaert; Françoise Neukirch; Jan P Schouten; Matthias Wjst; Peter Burney
Journal:  Am J Respir Crit Care Med       Date:  2006-09-28       Impact factor: 21.405

3.  Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.

Authors:  Andrea S Gershon; Chengning Wang; Andrew S Wilton; Roxana Raut; Teresa To
Journal:  Arch Intern Med       Date:  2010-03-22

4.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

5.  Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Abebaw M Yohannes; Robert C Baldwin; Martin J Connolly
Journal:  Age Ageing       Date:  2005-09       Impact factor: 10.668

6.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 7.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

8.  Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study.

Authors:  Yannick M T A van Durme; Katia M C Verhamme; Theo Stijnen; Frank J A van Rooij; Geert R Van Pottelberge; Albert Hofman; Guy F Joos; Bruno H Ch Stricker; Guy G Brusselle
Journal:  Chest       Date:  2009-02       Impact factor: 9.410

9.  Regional administrative health registries as a resource in clinical epidemiologyA study of options, strengths, limitations and data quality provided with examples of use.

Authors:  H T Sørensen
Journal:  Int J Risk Saf Med       Date:  1997

10.  Deaths from chronic obstructive pulmonary disease--United States, 2000-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586

View more
  11 in total

1.  Combined effect of lung function level and decline increases morbidity and mortality risks.

Authors:  Penelope Baughman; Jacob L Marott; Peter Lange; Christopher J Martin; Anoop Shankar; Edward L Petsonk; Eva Hnizdo
Journal:  Eur J Epidemiol       Date:  2012-12-14       Impact factor: 8.082

2.  Protocol for EXICODE: the EXIstential health COhort DEnmark-a register and survey study of adult Danes.

Authors:  Tobias Kvist Stripp; Sonja Wehberg; Arndt Büssing; Karen Andersen-Ranberg; Lars Henrik Jensen; Finn Henriksen; Christian B Laursen; Jens Søndergaard; Niels Christian Hvidt
Journal:  BMJ Open       Date:  2022-06-30       Impact factor: 3.006

3.  Hospitalisation for chronic obstructive pulmonary disease and risk of suicide: a population-based case-control study.

Authors:  Jennie Maria Christin Strid; Christian Fynbo Christiansen; Morten Olsen; Ping Qin
Journal:  BMJ Open       Date:  2014-11-24       Impact factor: 2.692

4.  The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.

Authors:  Sigrun Alba Johannesdottir Schmidt; Martin Berg Johansen; Morten Olsen; Xiao Xu; Joseph M Parker; Nestor A Molfino; Timothy L Lash; Henrik Toft Sørensen; Christian Fynbo Christiansen
Journal:  BMJ Open       Date:  2014-12-19       Impact factor: 2.692

5.  A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.

Authors:  Natasha Nanwa; Beate Sander; Murray Krahn; Nick Daneman; Hong Lu; Peter C Austin; Anand Govindarajan; Laura C Rosella; Suzanne M Cadarette; Jeffrey C Kwong
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

6.  Correlation of severity of chronic obstructive pulmonary disease with serum vitamin-D level.

Authors:  Ummul Baneen; Sufia Naseem
Journal:  J Family Med Prim Care       Date:  2019-07

7.  Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality--results from a 10-year prospective cohort study.

Authors:  Dennis Back Holmgaard; Lone Hagens Mygind; Ingrid Louise Titlestad; Hanne Madsen; Palle Bach Nielsen Fruekilde; Svend Stenvang Pedersen; C Pedersen
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

8.  Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease.

Authors:  Magnus P Ekström; Claes Jogréus; Kerstin E Ström
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

9.  Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality.

Authors:  Sigrun A J Schmidt; Johnny Kahlert; Mogens Vestergaard; Henrik C Schønheyder; Henrik T Sørensen
Journal:  BMC Infect Dis       Date:  2016-03-01       Impact factor: 3.090

10.  Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia.

Authors:  Mette Søgaard; Morten Madsen; Anders Løkke; Ole Hilberg; Henrik Toft Sørensen; Reimar W Thomsen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.